Correction: Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer

Oncogene. 2023 Apr;42(17):1418. doi: 10.1038/s41388-023-02654-1.

Ammara Abdullah¹, Saeed Salehin Akhand¹, Juan Sebastian Paez Paez¹, Wells Brown¹, Li Pan¹, Sarah Libring², Michael Badamy¹, Emily Dykuizen^{1

3}, Luis Solorio^{2

3}, W Andy Tao^{1

3}, Michael K Wendt^{4

5}

¹ Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, 47907, USA.
² Department of Biomedical Engineering, Purdue University, West Lafayette, IN, 47907, USA.
³ Purdue University Center for Cancer Research, Purdue University, West Lafayette, IN, 47907, USA.
⁴ Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, 47907, USA. mwendt@purdue.edu.
⁵ Purdue University Center for Cancer Research, Purdue University, West Lafayette, IN, 47907, USA. mwendt@purdue.edu.

No abstract available

Publication types